We exposed a wild type (DIFI), and two K-Ras mutant (HCT-116, DLD-1) CRC cell lines to various concentrations of C-13 for 2 hours and then measured cell proliferation, viability and apoptosis 72 hours post-treatment. This evidence concerns the gene KRAS and colorectal carcinoma.